| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy’s risk assessments do not identify all of the risks associated with the prescribing service or clearly explain how risks are managed. And it does not complete effective risk assessments when it introduces new treatment options or medicines to make sure the service the pharmacy provides is safe. |
A new medicine risk assessment tool is being created to review suitability of any new medications before application to the website. This assessment will comprise of product and prescribing risks and how it is mitigated and managed. Some of the pre listing assessments will include – Risk assessment finding and recommendations from assessors, Recommendation for Online Prescribing. Further Audits or Review will be required following initial assessment. |
08/06/2021 | 09/06/2021 |
| 1.2 | The pharmacy does not actively audit or review the prescribing service and adherence to prescribing polices, to make sure and show it is safe. |
New Audits will be commissioned and completed as quick as possible considering current covid pandemic, audits are taking longer than the usual time frame. Audits will be conducted regularly to ensure the prescribing policies are adhered to. |
08/06/2021 | 09/06/2021 |
| 3.1 | The pharmacy’s website is arranged so that a person selects a prescription only medicine (POM) before starting a consultation with a prescriber. And the website does not contain clear and accurate information about the prescriber to enable people to make an informed choice. |
1. Development of new patient pathway was already underway at the time of inspection. Prescription Doctor website will be less transactional and more consultation focused. 2. We shall edit the doctor profile page and remove any mention of GMC to avoid confusion. |
03/08/2021 | |
| 4.2 | The pharmacy is not able to demonstrate that safeguards are consistently used to make sure the medicines it supplies through the prescribing service are clinically appropriate. This includes:- verifying the information provided by the person completing the online questionnaire, sharing all relevant information about the prescription with the patient's regular doctor and ensuring effective monitoring is in place. |
Medications requiring additional monitoring such as levothyroxine, diabetic medications, Testogel, inhalers will require up to date checks, supporting documentations will be required. A 3,6 or 12 month assessment tool will be applied for medications such as levothyroxine and diabetes, the system will identify that up to date evidence/documentation will be required. For Testogel, this tool will identify evidence requirements every 6 months. Consultant documents and blood work would require Patient Name and Date of issue to be clearly stated. Saxenda 12-week Assessment tool will be applied, this tool works with algorithms rather than relying on manual monitoring which identifies the initial weight/BMI. After 12 weeks the system will automatically flag that the new order request requires a weight review, the BMI will be clearly stated and require assessment to see if 5% weight loss has been achieved as per criteria. Where a patient has given consent to share treatment information with their GP, our application will print and save the information sent and received to and from their patients GP. This information will be securely saved to their order profile/notes tab. Online health care is rapidly growing, PrescriptionDoctor shall continue to look at new ways to make their online health care A safe environment for professionals and patients. |
08/06/2021 | 09/06/2021 |
Pharmacy inspections
Inspection reports and learning from inspections